share_log

Marpai | 10-Q: Quarterly report

Marpai | 10-Q: Quarterly report

Marpai | 10-Q:季度報表
美股SEC公告 ·  08/07 17:27

Moomoo AI 已提取核心訊息

Marpai, Inc. (Marpai), a technology-driven healthcare third-party administrator, reported its financial performance for the quarter ended June 30, 2024. The company experienced a decrease in revenue to $7.2 million, down 28.4% from $10.0 million in the same quarter of the previous year. Operating loss widened to $12.3 million, a 68.8% increase from the prior year's $7.3 million. Net loss for the quarter was $13.0 million, compared to $7.6 million in the previous year, with a loss per share of $1.23. For the six-month period, revenue was $14.6 million, a 26.1% decrease from $19.7 million in the prior year, and net loss was $17.4 million, up from $16.4 million. The company recognized an impairment of goodwill and intangible assets amounting to $7.6 million. Marpai's business development includes the integration of two TPA companies...Show More
Marpai, Inc. (Marpai), a technology-driven healthcare third-party administrator, reported its financial performance for the quarter ended June 30, 2024. The company experienced a decrease in revenue to $7.2 million, down 28.4% from $10.0 million in the same quarter of the previous year. Operating loss widened to $12.3 million, a 68.8% increase from the prior year's $7.3 million. Net loss for the quarter was $13.0 million, compared to $7.6 million in the previous year, with a loss per share of $1.23. For the six-month period, revenue was $14.6 million, a 26.1% decrease from $19.7 million in the prior year, and net loss was $17.4 million, up from $16.4 million. The company recognized an impairment of goodwill and intangible assets amounting to $7.6 million. Marpai's business development includes the integration of two TPA companies and the elimination of non-value added services and development projects. The company is exploring strategic alternatives to maximize shareholder value, which may include a merger or sale. Marpai's financial statements have raised substantial doubt about its ability to continue as a going concern, with an accumulated deficit of $94.1 million and negative working capital of $1.5 million. The company's future plans involve raising additional capital or securing debt funding to support ongoing operations until it achieves cash self-sufficiency.
科技驅動的保健第三方管理機構Marpai公司公佈了截至2024年6月30日的財務業績。公司營業收入下降至720萬美元,較上一年同期的1000萬美元下降了28.4%。營業虧損擴大至1230萬美元,較去年同期的730萬美元增加了68.8%。該季度的淨虧損爲1300萬美元,而上一年爲760萬美元,每股虧損爲1.23美元。六個月的營業收入爲1460萬美元,較上一年的1970萬美元下降了26.1%,淨虧損爲1740萬美元,上一年爲1640萬美元。Marpai公司確認了760萬美元的商譽和無形資產減值。Marpai的業務發展包括整合兩家TPA公司和削減非增值服務和發展項目。該公司正在探索最大化股東價值的戰略選擇,可能包括合併或出售。Marpai的財務報表對其作爲企業持續運營的能力提出了實質性的質疑,累計赤字爲9410萬美元,負債流動資本爲150萬美元。該公司未來計劃是籌集額外的資金或獲得債務資金,以支持持續運營,直至實現自給自足的現金流。
科技驅動的保健第三方管理機構Marpai公司公佈了截至2024年6月30日的財務業績。公司營業收入下降至720萬美元,較上一年同期的1000萬美元下降了28.4%。營業虧損擴大至1230萬美元,較去年同期的730萬美元增加了68.8%。該季度的淨虧損爲1300萬美元,而上一年爲760萬美元,每股虧損爲1.23美元。六個月的營業收入爲1460萬美元,較上一年的1970萬美元下降了26.1%,淨虧損爲1740萬美元,上一年爲1640萬美元。Marpai公司確認了760萬美元的商譽和無形資產減值。Marpai的業務發展包括整合兩家TPA公司和削減非增值服務和發展項目。該公司正在探索最大化股東價值的戰略選擇,可能包括合併或出售。Marpai的財務報表對其作爲企業持續運營的能力提出了實質性的質疑,累計赤字爲9410萬美元,負債流動資本爲150萬美元。該公司未來計劃是籌集額外的資金或獲得債務資金,以支持持續運營,直至實現自給自足的現金流。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息